Recurrent Cerebral Infarction Due to Moyamoya Disease Complicated With Systemic Lupus Erythematosus
暂无分享,去创建一个
Jun-zhao Cui | Luji Liu | Yan Shen | Xiaoyun Liu | Yanying Zhao | Si Yuan | Qisong Wang | Yipu Zhu | Jing Tian | Jin Qin | Q. Yao | Yicong Zhou | Ruijie Zhao | Yang Feng | Lijuan Liu
[1] B. Hu,et al. Clinical efficacy analysis of butylphthalide combined with urinary kallidinogenase in treating chronic cerebral circulatory insufficiency , 2023, Brain and behavior.
[2] S. Dubey,et al. Moyamoya angiopathy unmasking systemic lupus erythematosus , 2021, BMJ Case Reports.
[3] Gyeong-Moon Kim,et al. Role of the RNF213 Variant in Vascular Outcomes in Patients With Intracranial Atherosclerosis , 2020, Journal of the American Heart Association.
[4] Wanyang Liu,et al. Meta‐analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease , 2020, European journal of neurology.
[5] Dong-Sook Kim,et al. Familial Risk for Moyamoya Disease Among First-Degree Relatives, Based on a Population-Based Aggregation Study in Korea , 2020, Stroke.
[6] J. Buyon,et al. Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis. , 2020, Mayo Clinic proceedings.
[7] Seung-Chyul Hong,et al. Moyamoya Disease and Spectrums of RNF213 Vasculopathy , 2019, Translational Stroke Research.
[8] H. Maruyama,et al. Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis. , 2019, Stroke.
[9] C. Gordon,et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus , 2019, Annals of the rheumatic diseases.
[10] M. Chimenti,et al. Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view. , 2019, Autoimmunity reviews.
[11] Y. Liu,et al. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report , 2018, Clinical Neurology and Neurosurgery.
[12] Zhen-Ni Guo,et al. Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence , 2017, International journal of stroke : official journal of the International Stroke Society.
[13] H. Yoo,et al. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. , 2016, Journal of neurosurgery.
[14] Melvyn W B Zhang,et al. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. , 2016, Autoimmunity reviews.
[15] T. Huizinga,et al. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives , 2016, Drugs.
[16] Jong S. Kim. Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis , 2016, Journal of stroke.
[17] Sukhum Silpa-archa,et al. Ocular manifestations in systemic lupus erythematosus , 2015, British Journal of Ophthalmology.
[18] S. Muller,et al. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers , 2014, Nature Reviews Neurology.
[19] J. Hanly. Diagnosis and management of neuropsychiatric SLE , 2014, Nature Reviews Rheumatology.
[20] T. Tominaga,et al. Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene , 2014, Journal of stroke.
[21] H. Ahn,et al. Incidence, Prevalence, and Survival of Moyamoya Disease in Korea: A Nationwide, Population-Based Study , 2014, Stroke.
[22] S. Nam,et al. Moyamoya syndrome occurred in a girl with an inactive systemic lupus erythematosus , 2013, Korean journal of pediatrics.
[23] S. Gokhale,et al. Moyamoya Syndrome as an Unusual Presenting Manifestation of Systemic Lupus Erythematosus in a Young Woman , 2013, Medical Principles and Practice.
[24] Y. Xu,et al. Systemic lupus erythematosus associated with moyamoya syndrome: a case report and literature review , 2013, Lupus.
[25] R. Zong,et al. Moyamoya Disease in China: Its Clinical Features and Outcomes , 2012, Stroke.
[26] C. Mok,et al. Moyamoya phenomenon in systemic lupus erythematosus. , 2011, Rheumatology.
[27] S. Steens,et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. , 2011, Arthritis and rheumatism.
[28] B. Bendok,et al. Moyamoya disease: a summary. , 2009, Neurosurgical focus.
[29] Young Jin Kim,et al. Moyamoya syndrome associated with systemic lupus erythematosus , 2008, Lupus.
[30] S. Kuroda,et al. Novel epidemiological features of moyamoya disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[31] W. Chung,et al. Systemic Lupus Erythematosus Associated with Familial Moyamoya Disease , 2003, The Korean journal of internal medicine.
[32] K. E. el Ramahi,et al. Systemic lupus erythematosus associated with moyamoya syndrome , 2000, Lupus.
[33] Caroline Gordon,et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.
[34] M. Kiriakidou,et al. Systemic Lupus Erythematosus , 1991, Annals of Internal Medicine.
[35] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.